Baird Financial Group, Inc. Royalty Pharma PLC Transaction History
Baird Financial Group, Inc.
- $54.4 Billion
- Q2 2025
A detailed history of Baird Financial Group, Inc. transactions in Royalty Pharma PLC stock. As of the latest transaction made, Baird Financial Group, Inc. holds 39,926 shares of RPRX stock, worth $1.54 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
39,926
Previous 51,181
21.99%
Holding current value
$1.54 Million
Previous $1.59 Million
9.73%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding RPRX
# of Institutions
509Shares Held
284MCall Options Held
1.99MPut Options Held
384K-
Morgan Stanley New York, NY46.6MShares$1.8 Billion0.11% of portfolio
-
Black Rock Inc. New York, NY23MShares$888 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA21.9MShares$844 Million0.14% of portfolio
-
Baillie Gifford & CO17.4MShares$670 Million0.48% of portfolio
-
Swedbank Ab Stockholm, V712.2MShares$470 Million0.45% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $16.9B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...